Signal Transduction Pathways Underlying the Expression of Tissue Factor and Thrombomodulin in Promyelocytic Cells Induced to Differentiate by Retinoid Acid and Dibutyryl cAMP

Summary

Acute promyelocytic leukaemia (APL) may be associated with disseminated intravascular coagulation, as a result of increased tissue factor (TF) expression and reduced thrombomodulin (TM) expression by APL blast cells. During retinoid acid (RA)- and dibutyryl cAMP (dbcAMP)-induced differentiation of the APL cells, there is a marked up-modulation of both the protein kinase A (PKA) and C (PKC) activities. In order to further assess whether these kinases are intimately associated with both the differentiation process and the regulation of TF and TM expression, we have correlated the modulation of their respective pathways with the extent of differentiation and modulation of these cellular receptors. NB4 cells were incubated with all-trans-RA (ATRA) or dbcAMP for up to 48 h. The contribution of phospholipase C (PLC), inositol phosphate (IP), PKC and PKA in the expression of CD11b, TF and TM was studied by the use of specific inhibitors. Myo-inositol uptake and PKC activity increased in cells induced to differentiate by ATRA but the retinoid did not affect cAMP levels or PKA activity. Under treatment with dbcAMP, PKA activity was increased while inositol uptake and PKC activity remained unchanged. Our results show that the effects of ATRA and dbcAMP on promyelocytic cells are closely related, respectively, to the PLC/IP/PKC and the cAMP/PKA pathways. In cells induced to differentiate by ATRA, CD11b expression seems more closely related to inositol uptake than to PKC activity while the expression of TF and TM show the opposite pattern, which suggests cellular events regulated at a different level within a common signal transduction pathway.

Key words

Cell differentiation - promyelocytic cells - signal transduction - tissue factor - thrombomodulin

• References

• 1 Fenaux P, Chomienne C, Degos L. Acute promyelocytic leukaemia: biology and treatment. Semin Oncol 1997; 24: 92-102.
• 2 Tallman MS, Kwaan HC. Reassessing the hemostatic disorder associated with acute promyelocytic leukaemia. Blood 1992; 79: 543-53.
• 3 Koyama T, Hirosawa S, Kawamata N, Tohda S, Aoki N. All-trans-retinoic acid up-regulates thrombomodulin and down-regulates tissue factor expression in acute promyelocytic leukaemia cells: distinct expression of thrombomodulin and tissue factor in human leukaemic cells. Blood 1994; 84: 3001-9.
• 4 López-Pedrera Ch, Jardí M, Malagón MM, Inglés-Esteve J, Dorado G, Torres A, Félez J, Velasco F. Tissue factor (TF) and urokinase plasminogen activator receptor (uPAR) and bleeding complications in leukemic patients. Thromb Haemost 1997; 77: 62-70.
• 5 Falanga A, Consonni R, Marchetti M, Mielicki WP, Rambaldi A, Lanotte M, Gordon SG, Barbui T. Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by retinoic acid. Leukemia 1994; 8: 156-9.
• 6 Falanga A, Iacoviello L, Evangelista V, Belotti D, D’Orazio A, Consonni R, Donati MB, Barbui T. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia on all-trans-retinoic acid. Blood 1995; 86: 1072-81.
• 7 Collins S. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogen expression. Blood 1987; 70: 1233-44.
• 8 Leid M, Kastner P, Durand B, Krust A, Leroy P, Lyons R, Mendelsohn C, Nagpal S, Nakshatri H, Reibel C. Retinoic acid signal transduction pathways. Ann NY Acad Sci 1993; 684: 19-34.
• 9 Mountford JC, Bunce CM, French PJ, Michel RH, Brown G. Intracellular concentration of inositol, glycerophosphoinositol and inositol pentakis-phosphate increase during haemopoietic cell differentiation. Biochim Biophys Acta 1994; 1222: 101-8.
• 10 Liu JP. Protein kinase C and its substrates. Mol Cell Endocrinol 1996; 116: 1-29.
• 11 Morelli S, Bloland AR, Boland RL. Generation of inositol phosphates, diacylglycerol and calcium fluxes in myoblast treated with 1,25-dihydroxyvitamin D3. Biochem J 1993; 289: 675-9.
• 12 Lanotte M, Martin-Thouvenin V, Najman S, Ballerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991; 77: 1080-6.
• 13 Fontana JA, Elmer C, Ku K, McClung JK, Butcher FR, Durham LO. Cyclic AMP-dependent and independent protein kinases and protein phosphorylation in human promyelocytic leukemia (HL-60) cells induced to differentiate by retinoic acid. J Cell Physiol 1984; 120: 49-60.
• 14 Frank DA, Sartorelli AC. Regulation of protein phosphotyrosine content by changes in tyrosine kinase and protein phosphotyrosine phosphatase activities during induced granulocytic and monocytic differentiation of HL-60 leukemia cells. Biochem Bioph Res Co 1985; 140: 440-7.
• 15 Jonson GL, Viallancourt RR. Sequential protein kinase reactions controlling cell growth and differentiation. Curr Opin Cell Biol 1994; 6: 230-8.
• 16 Macfarlane DE, Manzel L. Activation of β-isozyme of protein kinase C (PKCβ) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. J Biol Chem 1994; 269: 4327-31.
• 17 Savickiene J, Gineitis A, Shanbhag VP, Stigbrand T. Protein kinase inhibitors exert stage specific and inducer dependent effects on HL-60 cell differentiation. Anticancer Res 1995; 15: 687-92.
• 18 Melo JV. Insights into the molecular pathophysiology of chronic myeloid leukemia: targets for therapeutic strategies?. Hematology 1999; 143-51.
• 19 Senderowicz AM. Cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies. Hematology 1999; 454-62.
• 20 Cho-Chung YS. Role of cAMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res 1990; 50: 7093-100.
• 21 Duprez E, Ruchaud S, Houge GA. A retinoid “resistant” t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features. Leukemia 1992; 6: 1281-7.
• 22 Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethyl sulfoxide. J Exp Med 1979; 149: 969-75.
• 23 Dobado-Berrios PM, López-Pedrera Ch, Velasco F, Aguirre MA, Torres A, Cuadrado MJ. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemost 1999; 82: 1578-82.
• 24 Bijsterbosch MK, Klaus GG. Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors. J Exp Med 1985; 162: 1825-36.
• 25 Ido M, Nagao Y, Higashigawa M, Shibata T, Taniguchi K, Hamazaki M, Sakurai M. Differential growth inhibition of isoquinolinesulfonamides H-8 and H-7 towards multidrug resistant P388 murine leukaemia cells. Brit J Cancer 1991; 64: 1103-8.
• 26 Hagiwara M, Inagaki M, Hidaka H. Specific binding of a novel compound, N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide (H-8) to the active site of cAMP-dependent protein kinase. Mol Pharmacol 1987; 31: 523-8.
• 27 Wang XD, Kiang JG, Smallridge RC. A phospholipase C inhibitor, U73122, blocks TSH-induced inositol triphosphate production, Ca²⁺ increase and arachidonic acid release in FRTL-5 thyroid cells. Biochim Biophys Acta 1994; 1223: 101-6.
• 28 Koh DS, Reid G, Vogel W. Activating effect of the flavonoid phloretin on Ca²⁺-activated K⁺ channels in myelinated nerve fibers of Xenopus laevis. Neurosci Lett 1994; 165: 167-74.
• 29 Morreale de Escobar G, Calvo R, Escobar del Rey F, Obregon MJ. Thyroid hormones in tissues from fetal and adult rats. Endocrinology 1994; 134: 2410-9.
• 30 House C, Kemp BE. Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science 1987; 238: 1726-9.
• 31 Falanga A, Consonni R, Marchetti M, Locatelli G, Garattini E, Gambacorti Passerini C, Gordon SG, Barbui T. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood 1998; 92: 143-51.
• 32 Savickiene J, Gineitis A, Shanbhag VP, Stigbrand T. Relationship between differentiation mechanisms involving cAMP-dependent protein kinase and protein kinase C in uninduced and differentiating HL-60 cells. Anticancer Res 1997; 17: 285-92.
• 33 Duprez E, Lillehang JR, Gaub MP, Lanotte M. Differential changes of retinoid-X-receptor (RXRα) and its RARα and PML-RARα partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells. Oncogene 1996; 12: 2443-50.